AbbVie : ABBV

All AbbVie Articles

565 Articles

Lee Jackson | Sep 16, 2020 at 7:30 AM EDT

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

These five Dividend Aristocrats have sizable upside to the Wall Street targets and pay at least 4%. In a market…

Paul Ausick | Sep 10, 2020 at 8:12 AM EDT

8 Overlooked Companies That Keep Raising Dividends Ever Higher

A hot equity market from some popular stocks has overshadowed the steady payouts from many, less spectacular, but reliable companies.…

Lee Jackson | Aug 27, 2020 at 8:50 AM EDT

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of…

Jon C. Ogg | Aug 3, 2020 at 9:18 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm,…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Jon C. Ogg | Jun 23, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe's, Micron Technology, Nike, PG&E, ViacomCBS, YETI…

Chris Lange | Jun 18, 2020 at 10:21 AM EDT

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.

Jon C. Ogg | Jun 2, 2020 at 11:29 AM EDT

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira,…

Jon C. Ogg | Jun 2, 2020 at 8:53 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

Tuesday's top analyst upgrades and downgrades included AbbVie, ANGI Homeservices, CBOE, Darden Restaurants, Hess, Lululemon Athletica, MongoDB, PayPal, Shopify, Slack…

Jon C. Ogg | May 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, AEP, AB InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG, T-Mobile, Walmart and More

Wednesday's top analyst upgrades and downgrades included AbbVie, American Electric Power, Anheuser-Busch InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon,…

Jon C. Ogg | May 11, 2020 at 9:13 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Best Buy, Conagra, Dick’s, GM, Hilton, NetApp, Nvidia, Redfin, TJX, Vale, Yelp and More

Monday's top analyst upgrades and downgrades included AbbVie, Best Buy, Conagra Brands, Dick's Sporting Goods, General Motors, Hilton Worldwide, NetApp,…

Chris Lange | Apr 27, 2020 at 9:37 AM EDT

Big Pharma Short Sellers Can’t Make Up Their Minds

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 20, 2020 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago…

Chris Lange | Apr 13, 2020 at 9:58 AM EDT

Big Pharma Short Sellers Focus on a Couple of Favorites

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Douglas A. McIntyre | Mar 31, 2020 at 12:29 PM EDT

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on…

1 … 11 12 13 14 15 … 38

AbbVie : ABBV

All AbbVie Articles

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

8 Overlooked Companies That Keep Raising Dividends Ever Higher

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

Top Analyst Upgrades and Downgrades: AbbVie, AEP, AB InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG, T-Mobile, Walmart and More

Top Analyst Upgrades and Downgrades: AbbVie, Best Buy, Conagra, Dick’s, GM, Hilton, NetApp, Nvidia, Redfin, TJX, Vale, Yelp and More

Big Pharma Short Sellers Can’t Make Up Their Minds

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Big Pharma Short Sellers Focus on a Couple of Favorites

Co-Diagnostics Stock Is Not a Penny Stock Anymore

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

AbbVie : ABBV

All AbbVie Articles

5 Dividend Aristocrat Stocks That Are Quietly Offering Huge Total Return Potential

8 Overlooked Companies That Keep Raising Dividends Ever Higher

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Top Analyst Upgrades and Downgrades: AbbVie, DuPont, Etsy, Expedia, Exxon, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, SolarEdge, Visa, Yum and More

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Top Analyst Upgrades and Downgrades: AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe’s, Micron, Nike, PG&E, ViacomCBS, YETI, Yext and More

Has Alpine Immune Sciences Found the Deal of a Lifetime?

Why AbbVie Could Have the Most Upside Among Big Pharma Stocks

Top Analyst Upgrades and Downgrades: AbbVie, ANGI, CBOE, Darden, Hess, Lululemon, MongoDB, PayPal, Shopify, Slack, Zynga and More

Top Analyst Upgrades and Downgrades: AbbVie, AEP, AB InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG, T-Mobile, Walmart and More

Top Analyst Upgrades and Downgrades: AbbVie, Best Buy, Conagra, Dick’s, GM, Hilton, NetApp, Nvidia, Redfin, TJX, Vale, Yelp and More

Big Pharma Short Sellers Can’t Make Up Their Minds

Top Analyst Upgrades and Downgrades: AbbVie, AEP, ANGI, Disney, DuPont, Gilead, Microsoft, Peloton, Shopify, Trivago and More

Big Pharma Short Sellers Focus on a Couple of Favorites

Co-Diagnostics Stock Is Not a Penny Stock Anymore

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It